(VIANEWS) – Shares of Arcturus Therapeutics (ARCT) jumped by a staggering 11.01% to $49.69 at 10:23 EST on Thursday, after three consecutive sessions in a row of gains. NASDAQ Composite is rising 0.34% to $14,830.70, after three sequential sessions in a row of gains. This seems, up to now, a somewhat up trend trading session today.
Arcturus Therapeutics’s last close was $58.25, 55.09% under its 52-week high of $129.71.
Today’s last reported volume for Arcturus Therapeutics is 392388 which is 39.63% below its average volume of 649957.
Arcturus Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 19.6%, now sitting on 9.02M for the twelve trailing months.
Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 1.27%, a negative 0.20%, and a positive 3.35%, respectively.
Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (last week), 3.22% (last month), and 3.35% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Arcturus Therapeutics’s stock is considered to be oversold (<=20).
Arcturus Therapeutics’s Stock Yearly Top and Bottom Value
Arcturus Therapeutics’s stock is valued at $49.69 at 10:23 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.
Arcturus Therapeutics’s Moving Average
Arcturus Therapeutics’s worth is way above its 50-day moving average of $33.21 and way above its 200-day moving average of $43.21.
More news about Arcturus Therapeutics (ARCT).